Axel Wester

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Biträdande lektor i epidemiologi med fokus på kronisk leversjukdom samt ST-läkare i klinisk farmakologi på Karolinska universitetssjukhuset Huddinge.
Medlem i Hannes Hagströms forskargrupp vid institutionen för medicin,
Huddinge: https://ki.se/en/medh/hagstrom-group

Artiklar

Journal article: CLINICAL AND MOLECULAR HEPATOLOGY. 2026
Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study.
Wester A; Grip ET; Rajani R; Matthews AA; Hagström H; Shang Y
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2026;149:106818
Risk of infection shortly before and after a diagnosis of liver cirrhosis: a nationwide, population-based study in Sweden
Steimer PA; Wester A; Shen Q; Hagstrom H; Shang Y
Article: ANNALS OF HEPATOLOGY. 2026;31(2):102172
Twofold increased risk of coronary artery disease after liver transplantation: A nationwide Swedish cohort of 2925 patients
Lewinter C; Widman L; Melin M; Wester A; Shang Y; Hagstrom H
Article: BMJ PUBLIC HEALTH. 2025;3(2):e003322
Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in Sweden
Boeckmans J; Widman L; Strandberg R; Shang Y; Wester A; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2025;60(11):1096-1103
Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in Sweden
Boeckmans J; Ullman S; Ludvigsson JF; Wester A; Wahlin S; Hagstrom H
Article: JOURNAL OF HEPATOLOGY. 2025;83(5):1011-1022
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
Vaz J; Nasr P; Helander A; Shang Y; Wester A; Strandberg R; Grip ET; Hagstrom H
Article: JOURNAL OF HEPATOLOGY. 2025;83(3):643-651
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Issa G; Shang Y; Strandberg R; Hagstrom H; Wester A
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2025;134:104-113
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study
Boeckmans J; Widman L; Shang Y; Strandberg R; Wester A; Schattenberg J; Hagstrom H
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025;61(1):109-121
Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients
Schechter MS; Widman L; Wester A; Shang Y; Stal P; Fortune B; Hagstroem H
Article: LIVER INTERNATIONAL. 2024;44(11):3050-3059
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
Nasr P; Shang Y; Wester A; Strandberg R; Widman L; Lazarus JV; Hagstrom H
Article: LIVER INTERNATIONAL. 2024;44(10):2551-2563
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
Astrom H; Shang Y; Hagstrom H; Wester A
Article: LIVER INTERNATIONAL. 2024;44(8):2002-2010
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study
Wester A; Jepsen P; Hagstrom H
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024;13(13):e034709
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
Hakansson A; Koul S; Omerovic E; Andersson J; James S; Agewall S; Mokhtari A; van der Pals J; Wester A; Szummer K; Jernberg T; Erlinge D; Mohammad MA
Article: LIVER INTERNATIONAL. 2024;44(7):1689-1699
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(5):1048-1057.e2
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagstrom H
Article: GUT. 2024;73(5):835-843
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
Wester A; Shang Y; Grip ET; Matthews AA; Hagstrom H
Article: GASTRO HEP ADVANCES. 2024;3(6):783-792
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver Disease
Michel M; Hagstroem H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3346-3355.e19
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study
Ebrahimi F; Simon TG; Hagstrom H; Soderling J; Wester A; Roelstraete B; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3336-3345.e2
Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients
Hagstroem H; Shang Y; Tapper EB; Wester A; Widman L
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1371
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
Haakansson A; Koul S; Omerovic E; Andersson J; Agewall S; James S; Mokhtari A; Van der Pals J; Wester A; Szummer K; Jernberg T; Erlinge D; Mohammad MA
Visa fler

Alla övriga publikationer

Letter: JOURNAL OF HEPATOLOGY. 2025;83(3):e152-e153
Reply to "Improving risk estimation in MASLD: Competing events and liver function reserve"
Wester A; Issa G; Hagstrom H
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(3):670
Secondary Prevention of Esophageal Variceal Bleeding: Still a Long Way to Go Reply
Hagstrom H; Shang Y; Tapper EB; Wester A; Widman L
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2024;62(01):e15
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):537-538
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis
Schoenau J; Wester A; Hagstrom H; Schattenberg JM
Conference publication: HEPATOLOGY. 2023;78:S395-S396
LOWER INCIDENCE OF HCC AND OTHER MAJOR ADVERSE LIVER OUTCOMES IN PEOPLE LIVING WITH HIV AND CHRONIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY
Michel M; Hagstrom H; Widman L; Nowak P; Shang Y; Schattenberg J; Wester A
Conference publication: HEPATOLOGY. 2023;78:S1668-S1669
UPTAKE OF SECONDARY PREVENTIVE DRUGS AFTER MYOCARDIAL INFARCTION IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE IS LOW: A NATIONWIDE POPULATION-BASED STUDY
Wester A; Hagstrom H; Jepsen P
Editorial: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(10):2689-2691.e1
Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study
Wester A; Aberg F; Rajani R; Hagstrom H
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2023;61(08):e472-e473
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(6):1678
Letter on "Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study" Reply
Wester A; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S1133-S1134
RISK OF INJURY BEFORE AND AFTER DIAGNOSIS OF CIRRHOSIS: A SELF-CONTROLLED CASE SERIES STUDY
Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S1491
RISK OF FRACTURES AND POST-FRACTURE MORTALITY IN PRIMARY BILIARY CHOLANGITIS: A POPULATION-BASED COHORT STUDY OF 3,980 PATIENTS
Wester A; Schoenau J; Schattenberg JM; Hagstroem H
Conference publication: HEPATOLOGY. 2022;76:S949
TIME TRENDS FOR MORTALITY AND LIFE EXPECTANCY IN 22,658 PATIENTS HOSPITALIZED WITH ALCOHOL-RELATED CIRRHOSIS IN SWEDEN: A NATIONWIDE COHORT STUDY
Wester A; Shang Y; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S423
The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD
Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S30
Liver stiffness predicts incident severe liver disease in patients with chronic liver disease
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S123
Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study
Wester A; Ndegwa N; Hagstrom H
Conference publication: EUROPEAN HEART JOURNAL. 2020;41:1435
External validation of the PRECISE-DAPT score in a large nationwide population of myocardial infarction patients: a SWEDEHEART study
Wester A; Mohammad MA; Erlinge D; Koul S
Conference publication: JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2017;70(18):B1
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: a SWEDEHEART study
Wester A; Mohammad M; Koul S; Andell P; Rylance R; Dankiewicz J; Friberg H; James S; Omerovic E; Erlinge D

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Handledning

Handledning till doktorsexamen

Nyheter från KI

Kalenderhändelser från KI